Logo

codevelopment agreement

Sophia Genetics Touts Informatics Deals With Weill Cornell, Agilent, Dasa
Premium

Fresh off its July IPO, the Swiss-American company is expanding its technological and geographical footprints with a series of collaborations and partnerships.

Thermo Fisher Scientific, AstraZeneca Team up to Develop CDx for Targeted Drugs

The next-generation sequencing based companion diagnostics will be paired with targeted therapies that are being developed for several diseases.

GenomSys, Philips to Build Genome Analysis Technology Based on MPEG-G Standard

The multiyear collaboration agreement brings together two of the corporate champions of the MPEG-G genomic data representation and compression standard.

Sophia Genetics Files for $100M IPO, Inks Cancer Data Deal With GE Healthcare

Sophia, which will trade on the Nasdaq, seeks to raise $100 million in an IPO, and separately announced a partnership with GE Healthcare.

Illumina, Kartos Therapeutics Partner to Develop TP53 Companion Diagnostic

The two companies will codevelop the next-generation sequencing test for Kartos's MDM2 inhibitor, KRT-232, being studied in TP53 wild-type blood cancers.

Apr 15, 2021

Trapelo Health, Magellan Hope to Ease Prior Authorization for Precision Oncology Testing
Premium

Feb 24, 2021

Qiagen, Inovio Expand CDx Partnership, Starting With NGS Test for Cervical Dysplasia Therapy

Feb 9, 2021

UK Startup Gabriel Precision Oncology Leans on Congenica to Broaden NGS Use in Cancer Testing
Premium

Nov 18, 2020

Agendia, Paige Partner to Codevelop New Assays Using MammaPrint, BluePrint Signatures

Aug 6, 2020

Biocept, Aegea to Develop PCR-based COVID-19 Assay Using Switch-Blocker Tech

Jul 17, 2020

Saga Diagnostics, SensID to Codevelop Control Reagents for Cancer Mutation Detection

Jul 1, 2020

Sherlock Biosciences, Binx Health Partner to Develop CRISPR-Based POC COVID-19 Test
Premium

May 5, 2020

CareDx, Weill Cornell Codeveloping Kidney Transplant Rejection Test

Mar 17, 2020

Illumina, IDbyDNA Ink Partnership on NGS Technologies for Infectious Disease

Jan 15, 2020

PGDx, Eisai to Develop Next-Generation Sequencing Biomarker Assay

Jan 13, 2020

Roche, Illumina Partner on Next-Generation Sequencing IVD, CDx Development, Marketing

Dec 3, 2019

Illumina, ArcherDx Expand Partnership on NGS IVD Tests

Nov 7, 2019

Lucence Diagnostics, MEDx Partner on Companion Diagnostic Cancer Tests in China

Nov 6, 2019

Mission Bio, BioLegend Partner on Single-Cell DNA-Protein Detection

Oct 4, 2019

Prometheus Biosciences, Takeda Pharmaceutical to Codevelop Targeted Therapies, CDx for IBD

Sep 24, 2019

Foundation Medicine, Natera to Develop Liquid Biopsy Monitoring Assays

Sep 16, 2019

Interpace Diagnostics, Genecast Biotechnology Ink Worldwide Research Services Agreement

Sep 11, 2019

Roche-GE Partnership Integrating Molecular Data Into Navify Tumor Board
Premium

May 31, 2019

Bruker Inks Consumables, Software Deals With PreOmics, Genedata

Mar 26, 2019

CDC, Group K Diagnostics Collaborate to Design, Evaluate Zika POC Test

Breaking News
The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.